01）、〈a class=singleStock target=_blank onmouseover=javascript:tip.createStockTips (event,hs_002821,凯莱英) href=/002821/〉凯莱英（002821）、〈a class=singleStock target=_blank onmouseover=javascript:tip.createStockTips (event,hs_002432,九安医疗) href=/002432/〉九安医疗（002432）回购金额上限均为12亿元，〈a class=singleStock target=_blank onmouseover=javascript:tip.createStockTips (event,hs_300347,泰格医药) href=/300347/〉泰格医药（300347）、〈a class=singleStock target=_blank onmouseover=javascript:tip.createStockTips (event,hs_002352,顺丰控股) href=/002352/〉顺丰控股（002352）、〈a class=singleStock target=_blank onmouseover=javascript:tip.createStockTips (event,hs_002008,大族激光) href=/002008/〉大族激光（002008）等多股回购金额上限为10亿元。值得注意的是，〈a class=singleStock target=_blank onmouseover=javascript:tip.createStockTips (event,hs_603259,药明康德) href=/603259/〉药明康德（603259）两次发布回购金额上限在10亿元的回购预案，合计20亿元。  在今年以来的回购潮中，实施注销式回购在A股上市公司中逐渐增多。药明康德、顺丰控股、〈a class=singleStock target=_bla
=*=*=*=*=*=
当前为第2/5页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页